Physician profile
David C Blease
NPI 1225057086
$2,215.10
in general payments reported to CMS, 2019-2025
23 companies · $476 in 2025
The $476 reported for 2025 was more than what 79% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $491 · 2023: $504 · 2024: $492 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $580.07 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Atricure, INC. | $366.09 | 2022-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medical Device Business Services, INC. | $162.78 | 2024 | Stratafix, Vistaseal, Evarrest |
| Medtronic, INC. | $137.25 | 2021-2025 | Endurant Iis |
| Boston Scientific Corporation | $121.06 | 2022-2025 | Embold Fibered, Eluvia |
| Shockwave Medical, INC | $115.22 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Getinge USA Sales, LLC | $111.55 | 2022-2024 | Vasoview Hemopro 2 |
| Inari Medical, INC. | $80.44 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $62.41 | 2022-2024 | Xarelto |
| Arthrex, INC. | $59.54 | 2024 | |
| Merck Sharp & Dohme LLC | $53.67 | 2023-2024 | Keytruda |
| Baxter Healthcare | $52.65 | 2022 | |
| Smith+Nephew, INC. | $52.18 | 2023-2024 | Pico, Oasis, Grafix Pl |
| Silk Road Medical, INC. | $37.22 | 2021 | |
| Elutia, INC. | $34.92 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.54 | 2025 | Repatha |
| Cvrx, INC. | $30.34 | 2024 | Barostim Neo System |
| Depuy Synthes Sales INC. | $28.65 | 2025 | Zipfix, Matrixrib |
| Lemaitre Vascular, INC. | $24.47 | 2022 | |
| Cardiva Medical, INC. | $21.04 | 2025 | Savvywire |
| Abiomed | $20.37 | 2025 | |
| Octapharma USA, INC. | $18.04 | 2025 | Fibryga |
| Davol INC. | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blease listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.